These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11673337)

  • 1. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up.
    Sousa JE; Costa MA; Abizaid AC; Rensing BJ; Abizaid AS; Tanajura LF; Kozuma K; Van Langenhove G; Sousa AG; Falotico R; Jaeger J; Popma JJ; Serruys PW
    Circulation; 2001 Oct; 104(17):2007-11. PubMed ID: 11673337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
    Degertekin M; Serruys PW; Foley DP; Tanabe K; Regar E; Vos J; Smits PC; van der Giessen WJ; van den Brand M; de Feyter P; Popma JJ
    Circulation; 2002 Sep; 106(13):1610-3. PubMed ID: 12270850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries.
    Sousa JE; Costa MA; Sousa AG; Abizaid AC; Seixas AC; Abizaid AS; Feres F; Mattos LA; Falotico R; Jaeger J; Popma JJ; Serruys PW
    Circulation; 2003 Jan; 107(3):381-3. PubMed ID: 12551858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial.
    Serruys PW; Degertekin M; Tanabe K; Abizaid A; Sousa JE; Colombo A; Guagliumi G; Wijns W; Lindeboom WK; Ligthart J; de Feyter PJ; Morice MC;
    Circulation; 2002 Aug; 106(7):798-803. PubMed ID: 12176950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents.
    Sousa JE; Costa MA; Abizaid A; Feres F; Seixas AC; Tanajura LF; Mattos LA; Falotico R; Jaeger J; Popma JJ; Serruys PW; Sousa AG
    Circulation; 2005 May; 111(18):2326-9. PubMed ID: 15851603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.
    Sousa JE; Costa MA; Abizaid A; Sousa AG; Feres F; Mattos LA; Centemero M; Maldonado G; Abizaid AS; Pinto I; Falotico R; Jaeger J; Popma JJ; Serruys PW
    Circulation; 2003 Jan; 107(1):24-7. PubMed ID: 12515737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.
    Sousa JE; Costa MA; Abizaid A; Abizaid AS; Feres F; Pinto IM; Seixas AC; Staico R; Mattos LA; Sousa AG; Falotico R; Jaeger J; Popma JJ; Serruys PW
    Circulation; 2001 Jan; 103(2):192-5. PubMed ID: 11208675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.
    Rensing BJ; Vos J; Smits PC; Foley DP; van den Brand MJ; van der Giessen WJ; de Feijter PJ; Serruys PW
    Eur Heart J; 2001 Nov; 22(22):2125-30. PubMed ID: 11686669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study".
    Cervinka P; Costa MA; Angiolillo DJ; Spacek R; Bystron M; Kvasnák M; Veselka J; Nanda H; Futamatsu H; Futamatsu K
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):846-51. PubMed ID: 16683273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.
    Jensen LO; Maeng M; Thayssen P; Villadsen A; Krusell L; Botker HE; Pedersen KE; Aaroe J; Christiansen EH; Vesterlund T; Hansen KN; Ravkilde J; Tilsted HH; Lassen JF; Thuesen L
    EuroIntervention; 2011 Jul; 7(3):323-31. PubMed ID: 21729834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Images in Cardiovascular Medicine. True three-dimensional reconstructed images showing lumen enlargement after sirolimus-eluting stent implantation.
    Tanabe K; Gijsen FJ; Degertekin M; Ligthart JM; Oortman RM; Serruys PW; Slager CJ
    Circulation; 2002 Nov; 106(22):e179-80. PubMed ID: 12451017
    [No Abstract]   [Full Text] [Related]  

  • 13. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.
    Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ;
    Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial.
    Kaneda H; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ;
    Int J Cardiol; 2010 Jan; 138(2):126-30. PubMed ID: 18804877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioactive stents delay but do not prevent in-stent neointimal hyperplasia.
    Kay IP; Wardeh AJ; Kozuma K; Foley DP; Knook AH; Thury A; Sianos G; van der Giessen WJ; Levendag PC; Serruys PW
    Circulation; 2001 Jan; 103(1):14-7. PubMed ID: 11136678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiographic and volumetric intravascular ultrasound comparison between direct sirolimus-eluting stent implantation versus predilation.
    Muñoz JS; Abizaid A; Albertal M; Mintz GS; Graebin R; Feres F; Staico R; Mattos LA; Tanajura LF; Abizaid AS; Sousa A; Sousa JE
    Am J Cardiol; 2004 Jun; 93(12):1522-5. PubMed ID: 15194025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of intravascular ultrasound lesion characteristics on neointimal hyperplasia following sirolimus-eluting stent implantation.
    Kaneda H; Koizumi T; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ
    Am J Cardiol; 2005 Nov; 96(9):1237-41. PubMed ID: 16253589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.